Salute e Benessere

Women's Digital Health Market Set to Expand Rapidly, Driven by Rising Chronic…

Rising Chronic Diseases Fuel Women's Digital Health Market Demand Rising Chronic Diseases Fuel Women's Digital Health Market Demand The escalating incidence of chronic diseases among women is a significant factor contributing to the growth of thewomen's digital health market. InJanuary 2023, data from the ACS (American Chemical Society) Journal revealed an increase in the number of new cancer cases among women from 927,910 in 2021 to 934,870 in 2022. This alarming trend underscores...
PR Newswire
15/09/2023

RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235963408 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235963408 Browse in-depth TOC on "RNA Therapeutics Market"135 - Tables36 - Figures171 - Pages RNA Therapeutics Market Scope: The vaccines segment accounted for the largest share of the RNA therapeutics market in 2022. Based on product, the RNA therapeutics market is...
PR Newswire
15/09/2023

Infusion Pump Market size worth USD 22.79 Billion, Globally, by 2030 at 6.0%…

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=26268 Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample?rid=26268 Browse in-depth TOCon" Infusion Pump Market " 202 - Pages 126 – Tables 37 – Figures Global Infusion Pump Market: Insights, Growth Drivers, Outlook, and Key Players The global Infusion Pump Market is set to witness significant growth in the coming years, driven by several key factors,...
PR Newswire
15/09/2023

Weight-loss Programs Level Up With Smart Wearable Devices

Among the various health segments where wearable devices are prominent, the weight loss and weight management market stand out due to fast-growing demand. Obesity is a major public health concern as many individuals struggle with excess weight and are seeking weight management solutions and to reduce the risks of associated diseases such as diabetes, heart disease, stroke, and certain types of cancer. Overall, the global weight loss market size was valued at USD 260.7 Billion in 2022. It is…
PR Newswire
15/09/2023

Reminder: Sobi KOL investor event: Advancing the standard of care in haemophilia

The presentation can be followed live here or afterwards on sobi.com. The slides will be made available on sobi.com prior to the conference call. The presentation can be followed livehereor afterwards onsobi.com. The slides will be made available onsobi.comprior to the conference call. To participate in the conference call, please use the following dial-in details: Sweden : +46 (0)8 5051 0031United Kingdom : +44 (0) 207 107 06 13 For other countries, please get detailshere...
PR Newswire
15/09/2023

Vivoryon Therapeutics N.V. Extraordinary General Meeting Approved Appointment of…

Vivoryon Therapeutics N.V.Extraordinary General Meeting Approved Appointment of New Executive Directors to the Board Halle (Saale) / Munich, Germany, September15 , 2023– Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon , or the Company ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, held its Extraordinary General...
Nasdaq GlobeNewswire
15/09/2023

Pluxy Epil Pro 3 Removes Unwanted Facial Hair for up to 4 Weeks

Shaving is worse than pulling hair out from the roots. But waxing involves an uncomfortable grow-out phase and can irritate the skin, while plucking takes time and carries the danger of stray hairs. It's also pricey! When compared to plucking or waxing, Pluxy Epil Pro 3 hair removal is more effective and doesn't cause skin rashes, pricey appointments, or stray hairs. The user may rapidly obtain weeks-long silky skin at home! The best method for attaining durable smoothness is Pluxy Epil Pro 3…
PR Newswire
15/09/2023

Top 10 Rare Blood Cancer Symptoms Revealed at Novartis' Immersive Installation

"One of the challenges with MPNs is that symptoms often go under the radar and get confused with ageing or other conditions. For example, if someone is facing extreme fatigue or experiencing nights sweats, they may put this down to the menopause, or their time of life" commented Alisia O'Sullivan, MPN Voice. "More needs to be done to recognise and identify these symptoms early so that people living with the condition can seek help from medical professionals to better manage their…
PR Newswire
15/09/2023

OKYO Pharma Announces Closing of $4.0 Million Registered Direct Offering of…

LONDON and NEW YORK, Sept.15, 2023(GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED”), today announced the closing of its previously announced Company best efforts registered direct offering of 2,666,670 ordinary shares at an offering price of $1.50 per ordinary share conducted without an underwriter or placement agent to individuals and institutions...
Nasdaq GlobeNewswire
15/09/2023

BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to…

BBS-Bioactive Bone Substitutes Plc, Company announcement, 15 September 2023 at 1:00 p.m.BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd Conversion requests and prices BBS-Bioactive Bone Substitutes Plc ("BBS") has received two new requests from Riverfort Global Opportunities PCC Ltd ("Riverfort") to convert convertible notes into Company shares. 12 September 2023: A...
Nasdaq GlobeNewswire
15/09/2023

NICE recommends Idorsia's QUVIVIQ™ (daridorexant) for adults with chronic…

Dr David O'Regan, Consultant in Psychiatry and Sleep Medicine, London, commented: "Today's announcement by NICE represents a significant breakthrough for chronic insomnia patients. While other treatment options for insomnia are available, these may not be suitable for long-term use, effective for all patients or specifically licensed for the treatment of chronic insomnia. It's very encouraging that NICE has made this recommendation, and in doing so recognise the importance of new…
PR Newswire
15/09/2023

Novartis shareholders approve the proposed 100% Spin-off of Sandoz

Shareholders approve the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of NovartisShareholders also approve a reduction of share capital in connection with the Spin-off Novartis shareholders and Novartis ADR holders will receive one Sandoz share for every five Novartis shares or one Sandoz ADR for every five Novartis ADRs through the distribution of a dividend-in-kindThe Spin-off is planned to occur on or around October 4, 2023Basel,...
Nasdaq GlobeNewswire
15/09/2023

Neoss® Group has launched a new wireless intraoral scanner, NeoScan™ 2000

NeoScan 2000 offers dental practitioners the ultimate digital impression solution. Its wireless technology liberates clinicians from the constraints of cables, allowing for unrestricted mobility during scanning. This freedom enables effortless capture of even the most challenging proximal areas, ensuring comprehensive and precise digital impressions. Its long-range connectivity ensures stable and uninterrupted data transfer, eliminating the need for constant repositioning or signal dropouts. ...
PR Newswire
15/09/2023

MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION…

This study is designed to change medical practice, as the majority of de novo coronary lesions are currently treated with a permanent metallic stent. SELUTION SLR consists of an angioplasty balloon coated with MicroReservoirs containing a mixture of biodegradable polymer and the anti-restenotic drug sirolimus. These MicroReservoirs provide controlled and sustained release of the drug for over 90 days, similar to a DES, but without leaving behind a metal stent, which has been associated with a…
PR Newswire
15/09/2023

Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts…

Key Takeaways from the Asthma Market Report Key Takeaways from the Asthma Market Report Discover which therapies are expected to grab the major asthma market share @Asthma Market Report Asthma Overview Asthma is a chronic respiratory condition that affects the airways in the lungs, causing them to become inflamed and narrowed. This leads to difficulty in breathing, coughing, wheezing, and chest tightness. Asthma symptoms can vary in severity and frequency, and they can be...
PR Newswire
14/09/2023

Transactions in Zealand Pharma shares and/or related securities by persons…

Company announcement – No. 35 / 2023 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, September 14, 2023–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or...
Nasdaq GlobeNewswire
14/09/2023

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of…

Company announcement – No. 34 / 2023 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, September 14, 2023–Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 20,102 divided into 20,102 new shares with a nominal value of DKK 1...
Nasdaq GlobeNewswire
14/09/2023

INTERNATIONAL MASTERCLASS

Spineway organizes an international masterclass with expert spine surgeons Spineway, a specialist in innovative implants for the treatment of severe spine disorders, announces that its Spineway Academy department, with the support ofGECO1 (Groupe d'études de la Chirurgie Osseuse – Bone Surgery Study Group) and its SAC (Spine Arthroplasty Community) working group, has organized a masterclass on cervical and lumbar disc prostheses with French and international surgeons...
Nasdaq GlobeNewswire
14/09/2023

Digital Biomarker Market Size to Grow USD 22360 Million by 2029 at a CAGR of…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6Y6173/Global_Digital_Biomarker_Market Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-6Y6173/Global_Digital_Biomarker_Market Major Factors Driving the Growth of Digital Biomarker Market: The Digital Biomarker Market is anticipated to expand as a result of the quick uptake of connected digital devices and mobile health applications, rising smartphone usage, the introduction of new...
PR Newswire
14/09/2023

Advances in HPV Disease Landscape: Enhancing Drug Development, Product…

HPV Disease Overview HPV Disease Overview HPV is a group of viruses that infect the epithelial cells of the skin and mucous membranes. Major question is: Is HPV contagious? It is the most common sexually transmitted infection globally. HPV infections are categorized into low-risk and high-risk types, with the latter being associated with various cancers, including cervical, anal, oropharyngeal, throat cancer, and penile cancer. Diagnostic Analysis Accurate diagnosis is pivotal for...
PR Newswire
14/09/2023

Stretch Marks Treatment Market to Grow Significantly by 2029- Brandessence…

This market study document curated by Brandessence Market Research is envisioned at empowering the business holders with a thorough knowledge about this industry. Growing drivers, opportunities, challenges, and restraints are well elaborated in this report. Apart from that, the major segments and regions are evaluated accurately with an aim to determine the size and scope of the overall market. The key players are highlighted with prime emphasis on their revenue streams, market performance…
PR Newswire
14/09/2023

Positive results from the Phase II study of uTRACE in brain cancer presented at…

The Phase II study was carried out in 24 glioma patients, 22 with high-grade gliomas and 2 with low-grade gliomas. Of the high-grade gliomas, 16 were grade IV (Glioblastomas). All 24 patients underwent a uPAR-PET scan with 68Ga-NOTA-AE105 (uTRACE®), and tumor uptake was evaluated as SUV values. The patients were followed over time to assess progression-free survival (PFS) and overall survival (OS). Patients were divided into high and low uPAR groups. Of the Glioblastomas 94% (15 of 16) were…
PR Newswire
14/09/2023

Navigating Diverticulitis Market: Clinical Viewpoints, Pipeline Development, &…

A Growing Global Concern: Expanding Horizons of Diverticulitis A Growing Global Concern: Expanding Horizons of Diverticulitis The incidence of diverticulitis constipation is escalating on a global scale, prompting significant lifestyle adjustments. The elevation of healthcare standards and the evolution of treatment methodologies are spawning fresh opportunities for industry players to thrive. Inthe United Statesalone, bladder diverticulum afflict over 50% of adults aged 60 and...
PR Newswire
14/09/2023

Notification of managers' transactions

ANNOUNCEMENT NO . 244 14 September 2023Notification of managers' transactionsChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.See the transactions of CEO Rasmus Kofoed in the attached PDF document. For further information, please contact:...
Nasdaq GlobeNewswire
14/09/2023
Altri  Comunicati